PDF herunterladen
CC BY 4.0 · Appl Clin Inform 2024; 15(02): 320-326
DOI: 10.1055/a-2297-4334
CIC 2023

Pharmacoinformatics-enabled Interventions Improved Care Coordination and Identified Pharmacy-Related Safety Issues in a Multicultural Medicare Population

Kelly J. T. Craig
1   Clinical Evidence Development, Aetna® Medical Affairs, CVS Health®, Hartford, Connecticut, United States
,
Amanda L. Zaleski
1   Clinical Evidence Development, Aetna® Medical Affairs, CVS Health®, Hartford, Connecticut, United States
,
Shannon M. MacKenzie
2   Aetna Medicare Strategic Programs, CVS Health, New York, New York, United States
,
Brenda L. Butler
3   Aetna Medicare Clinical Pharmacy, CVS Health, Hartford, Connecticut, United States
,
Rebecca A. Youngerman
4   Aetna Clinical Analytics & Behavior Change, CVS Health, New York, New York, United States
,
Sherrie L. McNutt
5   Aetna Medicare Clinical Services, CVS Health, Hartford, Connecticut, United States
,
Alena M. Baquet-Simpson
1   Clinical Evidence Development, Aetna® Medical Affairs, CVS Health®, Hartford, Connecticut, United States
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Background Compared to White populations, multicultural older adults experience more gaps in preventive care (e.g., vaccinations, screenings, chronic condition monitoring), social determinants of health barriers (e.g., access to care, language, transportation), and disparities and inequities (e.g., comorbidities, disease burden, and health care costs).

Objectives This study aims to describe an informatics-based approach used to execute and evaluate results of a member-centric, pharmacoinformatics-informed engagement program to deliver culturally tailored microinterventions to close medication-related gaps in care utilizing multidisciplinary care coordination that leverages the expanded role of the pharmacist. The operational framework will be described, and the influence of the medication use processes will be reported in a multicultural Medicare Advantage cohort.

Methods A pharmacoinformatics framework was leveraged to conduct a retrospective, observational cohort analysis of the program. Claims data were used to evaluate the influence of medication use process microinterventions from a large Medicare Advantage cohort of members who self-identify as Black and/or Hispanic, and have type 2 diabetes mellitus and/or hypertension, and meet eligibility criteria for multidisciplinary (e.g., nursing and pharmacy) care management (CM) and received pharmacy referral from January 1, 2022, through September 30, 2023.

Results A total of 3,265 Medicare Advantage members (78.3% Black and 21.7% Hispanic) received CM and pharmacy referral. Pharmacovigilance reviews conducted during this timeframe identified 258 acute events that escalated member CM. Provider outreach (n = 185) informed of safety issues (drug duplication, n = 48; drug interactions, n = 21; drug–disease interactions, n = 5; noncompliance and/or dosing issues, n = 27). Outreach to members (n = 160) and providers (n = 164) informed of open quality-related measure gaps for medication adherence.

Conclusion The application of pharmacoinformatics by a payor-led multicultural clinical program demonstrated quality improvements in Medicare Advantage member identification including risk stratification, timely outreach for pharmacy-related safety issues, and improved efficiency of multidisciplinary care coordination involving medication use process workflows.

Keywords

aged - medication adherence - medication therapy management - clinical informatics - chronic disease

Protection of Human and Animal Subjects

Sterling Institutional Review Board reviewed (#10311) and determined this study as exempt under 45 CFR 46.104(d)(4). In addition, a waiver of Health Insurance Portability and Accountability Act authorization for the use and disclosure of aggregated, de-identified member data was obtained.




Publikationsverlauf

Eingereicht: 30. Oktober 2023

Angenommen: 14. März 2024

Accepted Manuscript online:
01. April 2024

Artikel online veröffentlicht:
24. April 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Craig KJT, Bright TJ, Karunakaram H. et al. HPR55 How inequities and disparities in health & healthcare are impacting COVID-19 outcomes: a scoping review. Value Health 2022; 25 (07) S476
    CrossrefPubMedGoogle Scholar
  • 2 Lopez III L, Hart III LH, Katz MH. Racial and ethnic health disparities related to COVID-19. JAMA 2021; 325 (08) 719-720
    CrossrefPubMedGoogle Scholar
  • 3 2021 National Healthcare Quality and Disparities Report. Rockville, MD: Agency for Healthcare Research and Quality; ; December 2021. Accessed February 2, 2024 at https://www.ncbi.nlm.nih.gov/books/NBK578529/
    Google Scholar
  • 4 Ashton CM, Haidet P, Paterniti DA. et al. Racial and ethnic disparities in the use of health services: bias, preferences, or poor communication?. J Gen Intern Med 2003; 18 (02) 146-152
    CrossrefPubMedGoogle Scholar
  • 5 Martinez ML, Coles S. Addressing immunization health disparities. Prim Care 2020; 47 (03) 483-495
    CrossrefPubMedGoogle Scholar
  • 6 Adams LB, Richmond J, Corbie-Smith G, Powell W. Medical mistrust and colorectal cancer screening among African Americans. J Community Health 2017; 42 (05) 1044-1061
    CrossrefPubMedGoogle Scholar
  • 7 White RO, Beech BM, Miller S. Health care disparities and diabetes care: practical considerations for primary care providers. Clin Diabetes 2009; 27 (03) 105-112
    CrossrefPubMedGoogle Scholar
  • 8 Cheng CY, Reich D, Haiman CA. et al. African ancestry and its correlation to type 2 diabetes in African Americans: a genetic admixture analysis in three U.S. population cohorts. PLoS ONE 2012; 7 (03) e32840
    CrossrefPubMedGoogle Scholar
  • 9 Florez JC, Price AL, Campbell D. et al. Strong association of socioeconomic status with genetic ancestry in Latinos: implications for admixture studies of type 2 diabetes. Diabetologia 2009; 52 (08) 1528-1536
    CrossrefPubMedGoogle Scholar
  • 10 Kurian AK, Cardarelli KM. Racial and ethnic differences in cardiovascular disease risk factors: a systematic review. Ethn Dis 2007; 17 (01) 143-152
    PubMedGoogle Scholar
  • 11 Herman WH, Ma Y, Uwaifo G. et al; Diabetes Prevention Program Research Group. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007; 30 (10) 2453-2457
    CrossrefPubMedGoogle Scholar
  • 12 Thomas Craig KJ, Fusco N, Lindsley K. et al. Rapid review: Identification of digital health interventions in atherosclerotic-related cardiovascular disease populations to address racial, ethnic, and socioeconomic health disparities. Cardiovasc Digit Health J 2020; 1 (03) 139-148
    CrossrefPubMedGoogle Scholar
  • 13 Centers for Disease Control and Prevention. NCCDPHP Health Equity Glossary. Accessed February 8, 2024 at: https://www.cdc.gov/chronicdisease/healthequity/health-equity-communications/nccdphp-health-equity-glossary.html
    PubMedGoogle Scholar
  • 14 Bobo WV, Yawn BP, St Sauver JL, Grossardt BR, Boyd CM, Rocca WA. Prevalence of combined somatic and mental health multimorbidity: patterns by age, sex, and race/ethnicity. J Gerontol A Biol Sci Med Sci 2016; 71 (11) 1483-1491
    CrossrefPubMedGoogle Scholar
  • 15 Quiñones AR, Liang J, Bennett JM, Xu X, Ye W. How does the trajectory of multimorbidity vary across Black, White, and Mexican Americans in middle and old age?. J Gerontol B Psychol Sci Soc Sci 2011; 66 (06) 739-749
    CrossrefPubMedGoogle Scholar
  • 16 Hanlon C, Hinkle L. Assessing the costs of racial and ethnic health disparities: state experience. Rockville, MD: Healthcare Cost and Utilization Project (HCUP); ; June 2011
    Google Scholar
  • 17 Mueller C, Schur C, O'Connell J. Prescription drug spending: the impact of age and chronic disease status. Am J Public Health 1997; 87 (10) 1626-1629
    CrossrefPubMedGoogle Scholar
  • 18 Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002; 287 (03) 337-344
    CrossrefPubMedGoogle Scholar
  • 19 Centers for Medicare & Medicaid Services. Medication Therapy Management. 2023 . Accessed October 24, 2023 at: https://www.cms.gov/medicare/coverage/prescription-drug-coverage-contracting/medication-therapy-management
    PubMedGoogle Scholar
  • 20 Tajchman S, Lawler B, Spence N, Haque S, Quintana Y, Ateya M. Implementation and use of risk evaluation and mitigation strategies programs in practice: a scoping review of the literature. Appl Clin Inform 2022; 13 (05) 1151-1160
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 21 Baquet-Simpson AM, Craig KJT, MacKenzie SM. et al. Spotlight: a phased Medicare engagement to close gaps in preventive care for Black and Hispanic populations with type 2 diabetes mellitus and/or hypertension. J Health Care Poor Underserved 2022; 33 (05) 1-6
    PubMedGoogle Scholar
  • 22 U.S. Department of Health and Human Services. About the Affordable Care Act. Accessed October 24, 2023 at: https://www.hhs.gov/healthcare/about-the-aca/index.html
    PubMedGoogle Scholar
  • 23 Thompson CA. New health care laws will bring changes for pharmacists. Am J Health Syst Pharm 2010; 67 (09) 690-695
    CrossrefPubMedGoogle Scholar
  • 24 Carter BL, Foppe van Mil JW. Comparative effectiveness research: evaluating pharmacist interventions and strategies to improve medication adherence. Am J Hypertens 2010; 23 (09) 949-955
    CrossrefPubMedGoogle Scholar
  • 25 Schedlbauer A, Davies P, Fahey T. Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev 2010; (03) CD004371
    PubMedGoogle Scholar
  • 26 Jolivot PA, Hindlet P, Pichereau C. et al. A systematic review of adult admissions to ICUs related to adverse drug events. Crit Care 2014; 18 (06) 643
    CrossrefPubMedGoogle Scholar
  • 27 Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother 2008; 42 (07) 1017-1025
    CrossrefPubMedGoogle Scholar
  • 28 Agency for Healthcare Research and Quality. Medication Errors and Adverse Drug Events. 2019 . Accessed October 24, 2023 at: https://psnet.ahrq.gov/primer/medication-errors-and-adverse-drug-events
    PubMedGoogle Scholar
  • 29 Pedrós C, Quintana B, Rebolledo M, Porta N, Vallano A, Arnau JM. Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission. Eur J Clin Pharmacol 2014; 70 (03) 361-367
    CrossrefPubMedGoogle Scholar
  • 30 Zhang T, Gephart SM, Subbian V. et al. Barriers to adoption of tailored drug-drug interaction clinical decision support. Appl Clin Inform 2023; 14 (04) 779-788
    Artikel in Thieme ConnectPubMedGoogle Scholar